Right-to-health responsibilities of pharmaceutical companies

被引：0

|

作者：

不详

机构：

来源：

LANCET | 2009年 / 373卷 / 9680期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1998 / 1998

页数：1

相关论文

共 50 条

[21] Drugs for Life: How Pharmaceutical Companies Define Our Health
Ellis, Katie
SOMATECHNICS, 2014, 4 (01) : 189 - 191
[22] Drugs for Life: How Pharmaceutical Companies Define Our Health
McMillan, Alasdair
SCIENCE AS CULTURE, 2014, 23 (01) : 145 - 150
[23] Drugs for Life: How Pharmaceutical Companies Define Our Health
Meyers, Todd
BIOSOCIETIES, 2013, 8 (04) : 508 - 511
[24] Drugs for Life: How Pharmaceutical Companies Define our Health
Fisher, Jill A.
SOCIOLOGY OF HEALTH & ILLNESS, 2013, 35 (04) : 645 - 646
[25] Drugs for Life: How Pharmaceutical Companies Define Our Health
Hansen, Helena
AMERICAN ETHNOLOGIST, 2013, 40 (04) : 798 - 799
[26] Drugs for Life: How Pharmaceutical Companies Define Our Health
Sigurdson, Krista
EAST ASIAN SCIENCE TECHNOLOGY AND SOCIETY-AN INTERNATIONAL JOURNAL, 2015, 9 (03) : 311 - 314
[27] CASE: BIOETHICAL DISPUTES OF THE DONATIONS OF THE PHARMACEUTICAL COMPANIES TO THE HEALTH CENTERS
Gonzalez-Gonzalez, Abel
CUADERNOS DE BIOETICA, 2020, 31 (103): : 423 - 427
[28] Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
Sreedhar, D.
Janodia, M. D.
Ligade, V. S.
JOURNAL OF YOUNG PHARMACISTS, 2011, 3 (04) : 343 - 344
[29] Companies struggle with corporate social responsibilities
Brown, Bette Stallman
FRONTIERS IN ECOLOGY AND THE ENVIRONMENT, 2008, 6 (08) : 409 - 409
[30] RIGHT TO HEALTH AND "PHARMACEUTICAL CYCLE" IN THE PRISM OF CONSTITUTIONAL PRINCIPLES
Costanzo, Pasquale
BIOLAW JOURNAL-RIVISTA DI BIODIRITTO, 2019, (02): : 527 - 540

← 1 2 3 4 5 →